{
    "title": "US FDA panel votes against BrainStorm's ALS therapy over effectiveness concern",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12568699/US-FDA-panel-votes-against-BrainStorms-ALS-therapy.html",
    "date": "2023-09-27",
    "keywords": [
        "drug",
        "therapy",
        "approval",
        "brainstorm",
        "cell",
        "panel",
        "evidence",
        "agency",
        "fda",
        "disease",
        "effectiveness",
        "nurown",
        "treatment",
        "decision",
        "company",
        "nerve",
        "lindborg",
        "case",
        "application",
        "hope",
        "reporting",
        "health",
        "regulator",
        "wednesday",
        "sclerosis",
        "hurdle",
        "review",
        "mildtomoderate",
        "favor",
        "member",
        "backandforth",
        "communication",
        "benefit",
        "goal",
        "latestage",
        "study",
        "person",
        "harm",
        "run",
        "buckley",
        "subset",
        "degeneration",
        "coceo",
        "stacy",
        "statement",
        "data",
        "today",
        "biomarker",
        "response",
        "food",
        "staff",
        "monday",
        "companys",
        "probability",
        "outcome",
        "year",
        "group",
        "filing",
        "trial",
        "stem",
        "marrow",
        "growth",
        "firm",
        "riluzole",
        "relyvrio",
        "date",
        "qalsody",
        "agencys",
        "april",
        "advice",
        "dec",
        "mariam",
        "sunny",
        "deshmukh",
        "editing",
        "shinjini",
        "ganguli",
        "shounak",
        "dasgupta",
        "shweta",
        "agarwal"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}